Insider Trading Alert - FB, IDTI, TRLA, EPAM And GBX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Jan. 23, 2014, 79 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $54.30 to $9,617,994,000.00.

Highlighted Stocks Traded by Insiders:

Facebook Inc Class A (FB) - FREE Research Report

Ebersman David A who is Chief Financial Officer at Facebook Inc Class A sold 23,400 shares at $57.59 on Jan. 23, 2014. Following this transaction, the Chief Financial Officer owned 309,745 shares meaning that the stake was reduced by 7.02% with the 23,400-share transaction.

The shares most recently traded at $55.78, down $1.80, or 3.24% since the insider transaction. Historical insider transactions for Facebook Inc Class A go as follows:

  • 4-Week # shares sold: 392,734
  • 12-Week # shares sold: 2.9 million
  • 24-Week # shares sold: 3.9 million

The average volume for Facebook Inc Class A has been 70.6 million shares per day over the past 30 days. Facebook Inc Class A has a market cap of $108.1 billion and is part of the technology sector and internet industry. Shares are up 3.62% year-to-date as of the close of trading on Thursday.

Facebook, Inc. operates as a social networking company worldwide. It builds various tools that enable users to connect, share, discover, and communicate with each other on mobile devices and computers. The company has a P/E ratio of 140.3. Currently there are 29 analysts that rate Facebook Inc Class A a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FB - FREE

TheStreet Quant Ratings rates Facebook Inc Class A as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full Facebook Inc Class A Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Integrated Device Technology (IDTI) - FREE Research Report

Feld Peter A who is Director at Integrated Device Technology sold 33,950 shares at $11.06 on Jan. 23, 2014. Following this transaction, the Director owned 1.6 million shares meaning that the stake was reduced by 2.14% with the 33,950-share transaction.

The shares most recently traded at $10.65, down $0.41, or 3.81% since the insider transaction. Historical insider transactions for Integrated Device Technology go as follows:

  • 4-Week # shares sold: 1,891
  • 12-Week # shares bought: 20,000
  • 12-Week # shares sold: 1,891
  • 24-Week # shares bought: 60,000
  • 24-Week # shares sold: 11,025

The average volume for Integrated Device Technology has been 1.8 million shares per day over the past 30 days. Integrated Device Technology has a market cap of $1.7 billion and is part of the technology sector and electronics industry. Shares are up 6.29% year-to-date as of the close of trading on Thursday.

Integrated Device Technology, Inc. designs, develops, manufactures, and markets a range of mixed signal semiconductor solutions for the communications, computing, and consumer industries worldwide. It operates in two segments, Communications, and Computing and Consumer. The company has a P/E ratio of 26.1. Currently there are 2 analysts that rate Integrated Device Technology a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IDTI - FREE

TheStreet Quant Ratings rates Integrated Device Technology as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Integrated Device Technology Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Trulia (TRLA) - FREE Research Report

Inkinen Sami who is Director at Trulia sold 7,050 shares at $37.46 on Jan. 23, 2014. Following this transaction, the Director owned 845,303 shares meaning that the stake was reduced by 0.83% with the 7,050-share transaction.

The shares most recently traded at $36.44, down $1.02, or 2.8% since the insider transaction. Historical insider transactions for Trulia go as follows:

  • 4-Week # shares sold: 73,590
  • 12-Week # shares sold: 205,051
  • 24-Week # shares sold: 489,769

The average volume for Trulia has been 1.5 million shares per day over the past 30 days. Trulia has a market cap of $1.4 billion and is part of the technology sector and internet industry. Shares are up 7.43% year-to-date as of the close of trading on Thursday.

Trulia, Inc. provides tools to research homes and neighborhoods for consumers through Web and mobile applications. The company, through its tools, also enables real estate professionals to market their listings. The company has a P/E ratio of 256.6. Currently there are 4 analysts that rate Trulia a buy, 1 analyst rates it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TRLA - FREE

TheStreet Quant Ratings rates Trulia as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that net income has been generally deteriorating over time. Get the full Trulia Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

EPAM Systems (EPAM) - FREE Research Report

Robb Karl who is President of EU Operations,EVP at EPAM Systems sold 20,000 shares at $39.00 on Jan. 23, 2014. Following this transaction, the President of EU Operations,EVP owned 107,400 shares meaning that the stake was reduced by 15.7% with the 20,000-share transaction.

The shares most recently traded at $39.81, up $0.81, or 2.03% since the insider transaction. Historical insider transactions for EPAM Systems go as follows:

  • 4-Week # shares sold: 2.5 million
  • 12-Week # shares sold: 2.5 million
  • 24-Week # shares sold: 5.5 million

The average volume for EPAM Systems has been 349,000 shares per day over the past 30 days. EPAM Systems has a market cap of $1.9 billion and is part of the technology sector and computer software & services industry. Shares are up 14.22% year-to-date as of the close of trading on Thursday.

EPAM Systems, Inc., together with its subsidiaries, primarily provides software product development services worldwide. The company has a P/E ratio of 33.2. Currently there are 5 analysts that rate EPAM Systems a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EPAM - FREE

TheStreet Quant Ratings rates EPAM Systems as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and growth in earnings per share. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full EPAM Systems Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Greenbrier Companies (GBX) - FREE Research Report

Swindells Charles J who is Director at Greenbrier Companies sold 6,367 shares at $34.54 on Jan. 23, 2014. Following this transaction, the Director owned 22,901 shares meaning that the stake was reduced by 21.75% with the 6,367-share transaction.

Centurion Alejandro who is Pres GMO CEO Gunderson at Greenbrier Companies sold 3,000 shares at $37.07 on Jan. 23, 2014. Following this transaction, the Pres GMO CEO Gunderson owned 41,291 shares meaning that the stake was reduced by 6.77% with the 3,000-share transaction.

The shares most recently traded at $37.15, up $0.08, or 0.22% since the insider transaction. Historical insider transactions for Greenbrier Companies go as follows:

  • 4-Week # shares sold: 3,000
  • 12-Week # shares sold: 29,782
  • 24-Week # shares sold: 40,149

The average volume for Greenbrier Companies has been 416,100 shares per day over the past 30 days. Greenbrier Companies has a market cap of $1.0 billion and is part of the services sector and transportation industry. Shares are up 15.71% year-to-date as of the close of trading on Thursday.

The Greenbrier Companies, Inc. designs, manufactures, and markets railroad freight car equipment in North America and Europe. The stock currently has a dividend yield of 3.44%. Currently there are 9 analysts that rate Greenbrier Companies a buy, 1 analyst rates it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GBX - FREE

TheStreet Quant Ratings rates Greenbrier Companies as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and poor profit margins. Get the full Greenbrier Companies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Stocks Slide on Renewed Trade War Concerns

Stocks Slide on Renewed Trade War Concerns

Emerging Markets Get Pounded by Global Trade Concerns

Emerging Markets Get Pounded by Global Trade Concerns

PTC Shares Skyrocket on Positive Data for Spinal Muscular Atrophy Drug

PTC Shares Skyrocket on Positive Data for Spinal Muscular Atrophy Drug

Tesla Slumps After Mary McCormack Tweets Husband's Flaming Model S

Tesla Slumps After Mary McCormack Tweets Husband's Flaming Model S

Stocks Dive Globally as U.S.-China Trade War Intensifies

Stocks Dive Globally as U.S.-China Trade War Intensifies